Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells

Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells

US Patent 4975278 · Granted Dec 4, 1990

Estimated economic value: $13,359,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of inflammatory disease2025
Potent ASGPR-binding compounds for the degradation of immunoglobulins and other 2025
ASGPR-binding compounds for the degradation of extracellular proteins2025
ASGPR-binding compounds for the degradation of extracellular proteins2025
Hydrophilic antibody-drug conjugates2025
ASGPR-binding compounds for the degradation of extracellular proteins2024
Potent ASGPR-binding compounds for the degradation of immunoglobulins and other 2024
ASGPR-binding compounds for the degradation of extracellular proteins2024
Selective drug release from internalized conjugates of biologically active compo2024
ASGPR-binding compounds for the degradation of extracellular proteins2023
Hydrophilic antibody-drug conjugates2022
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency v2022